1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)M. Wislez,J. Mazieres,A. Lavole,G. Zalcman, O. Carre, T. Egenod, R. Caliandro,R. Gervais,G. Jeannin,O. Molinier,M.A. Massiani,A. Langlais,F. Morin,F. Le Pimpec Barthes,L. Brouchet,J. Assouad,B. Milleron,D. Damotte,M. Antoine,V. WesteelAnnals of Oncology（2020）引用 53|浏览56暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
